Status:

WITHDRAWN

Clinical Evaluation of HPT Treated Rigid Contact Lenses Made From Hexafocon A

Lead Sponsor:

Contamac Ltd

Conditions:

Ametropia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This will be an up to six months, subject-masked, contralateral, parallel-group, randomised, daily wear study. All subjects will wear the Test lens in one eye and the Control lens in the other eye. Da...

Eligibility Criteria

Inclusion

  • Willing and able to sign the informed consent form
  • Aged ≥18 years old
  • Experienced wearer of rigid gas permeable contact lenses
  • Subject's habitual contact lenses must be made of Boston XO (hexafocon A) material
  • Subjects must have owned spectacles or contact lenses prior to enrolment for this trial
  • Spherical power between -10.00 D and +10.00 D (at vertex distance 0 mm)
  • Corneal astigmatism ≤2.00 D

Exclusion

  • Eye injury or surgery within 3 months immediately prior to enrolment for this trial
  • Pre-existing ocular irritation that would preclude contact lens fitting
  • Currently enrolled in an ophthalmic clinical trial
  • Evidence of systemic or ocular abnormality, infection or disease which is likely to affect successful wear of contact lenses or use of the accessory solutions, as determined by the investigator
  • Any use of medications for which contact lens wear could be contradicted, as determined by the investigator
  • Current extended-wear users (sleep-in overnight)
  • Current monovision lens wearers
  • Current wearers of multifocal contact lenses
  • Current wearers of toric contact lenses (front surface design)
  • Current wearers of astigmatic contact lenses (posterior surface design)
  • Has a reported "Strong" comfort or vision preference between each eye with their habitual RGP lenses
  • Unacceptable fit of habitual lenses
  • Pregnant women and nursing mothers
  • Best-corrected visual acuity worse than 6/9 (LogMAR: +0.20; Snellen decimal: 0.63)

Key Trial Info

Start Date :

September 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2015

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04525170

Start Date

September 1 2015

End Date

December 1 2015

Last Update

August 25 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hartwig Research Center

Heikendorf, S-H, Germany, 24226

2

Siehste

Kassel, Germany